APP and Alzheimer disease: Central to both neurodegenerative pathologies is an analogous proteolytic processing of a membrane protein (APP in AD, and cellular PrP in prion disorders) that generates unstable, aggregation prone, neurotoxic fragments that are pathognomonic for each disease (Aβ peptides and PrPSc).